The association between CDKL3 and tumor progression was clearly indicated by the CDKL3 upregulation in prostate cancer tissues and its correlation with Gleason score and tumor stage, both of which are important characteristics of prostate cancer. The gene discussed is CDKL3; the disease is prostate carcinoma.